+

Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

Email Address*(Required)

What is Your Specialty?*(Required)

Select all that apply (Select at least one)*

What are your goals for visiting NephU?(Required)

Learn about IgAN MOD and disease progression

Join the NephU community

Access additional IgAN resources

Select all that apply (Select at least one)*

How would you like to hear from us?(Required)

Biweekly Email Newsletters

Schedule a Meeting with a Medical Science Liaison

Learn About Upcoming Live/Virtual Events

Agree(Required)

By providing your name, email address, and other information, you are giving Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and companies working with OPDC permission to send you information from NephU. OPDC will not sell or transfer your name, address, or email address. You agree that should you use any material provided through NephU, you will attribute the source of that information to “NephU sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.” For additional information, please read our Privacy Policy. By submitting your information, you agree to the terms provided above, and the terms provided in our Terms of Use and our Privacy Policy.

*Required Field

All Resources

A Call For Health Equity To Address Racial Disparities In Patients Diagnosed With ADPKD

Infographic May 23, 2022

This infographic describes the call to action in improving health equity and racial disparities for patients diagnosed with ADPKD. Read More

Mindfulness Self-Care Practices Benefits Nephrology Health Care Providers

Article May 17, 2022

Even the most resilient health care providers can suffer from fatigue and burnout. This article reviews mindfulness self-care practices. Read More

Infographic – Why Is Racial & Ethnic Diversity Important In Kidney Disease Clinical Trials?

Infographic May 13, 2022

Dive into our NephU resources! This infographic reviews just part of the reason why racial and ethnic diversity is important to kidney disease clinical trials. Read More

Infographic – The “Four Hit” IgA Nephropathy (IgAN) Pathogenesis Theory

Infographic May 13, 2022

This infographic reviews the four hit pathogenesis theory for IgA Nephropathy (IgAN). Read More

Caring for You & Your Loved One With ADPKD – Spanish

Printable Handouts May 12, 2022

Hablar sobre su afección y diagnóstico de poliquistosis renal autosómica dominante, o ADPKD por sus siglas en inglés, es su decisión. Read More

Talking With Your Family & Friends – Spanish

Printable Handouts May 12, 2022

Hablar sobre su afección y diagnóstico de poliquistosis renal autosómica dominante, o ADPKD por sus siglas en inglés, es su decisión. Read More

At Risk for ADPKD: A Guide for Talking About ADPKD – Spanish

Printable Handouts May 12, 2022

La poliquistosis renal autosómica dominante, o ADPKD por sus siglas en inglés, representa la mayor parte de los casosde riñón poliquístico (9 de 10). Algunas personas con ADPKD están en… Read More

Supporting Your Loved One With ADPKD – Spanish

Printable Handouts May 12, 2022

Hablar sobre la ADPKD es una decisión personal y puede ser difícil para su ser querido que enfrenta esta afección. Read More

Where Can I Find Help for ADPKD – Spanish

Printable Handouts May 12, 2022

Hay muchas organizaciones y recursos disponibles en la comunidad sobre la enfermedad renal poliquística, o PKD por sus siglas en inglés, para ayudarlo a usted y a su ser querido… Read More

Talking With Your Employer – Spanish

Printable Handouts May 12, 2022

Hablar sobre su afección y diagnóstico de poliquistosis renal autosómica dominante, o ADPKD por sus siglas en inglés, es su decisión. Read More

By becoming a Supporting Organization, you will receive the opportunity to:

Promote your organization’s logo and brief description to NephU’s 8,000+ members on the NephU Supporting Organizations page
Collaborate, develop, and cross promote resources and events
Submit published articles, resources, or relevant materials to the NephU Resource Library

*Note: Event postings, potential cross promotional materials, interviews, and resources are subject to the legal review process of NephU’s sponsor Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC).

NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.

May 2020 MRC2.CORP.X.04767

August 2024 US.CORP.X.24.00265

©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.